Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
about
Healthcare costs associated with change in body mass index in patients with type 2 diabetes mellitus in Spain: the ECOBIM study.Efficacy and safety of canagliflozin in patients with type 2 diabetes based on history of cardiovascular disease or cardiovascular risk factors: a post hoc analysis of pooled data.Atherosclerotic cardiovascular disease among patients with type 2 diabetes in Basrah.The effect of glucagon-like peptide 1 on cardiovascular risk.Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review.Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus stratified by cardiovascular disease history and cardiovascular risk factors: analysis of 3 clinical trials.Differential DNA methylation status between human preadipocytes and mature adipocytes.Cardiovascular disease predicts diabetic peripheral polyneuropathy in subjects with type 2 diabetes: A 10-year prospective study.Effects of exenatide on systolic blood pressure in subjects with type 2 diabetes.Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.Assessment of cardiovascular risk in adults with type 2 diabetes and metabolic syndrome: Framingham versus UKPDS equations.Thoracic periaortic adipose tissue in relation to cardiovascular risk in type 2 diabetes mellitus.Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus and cardiovascular disease history or cardiovascular risk factors: results of a pooled analysis of phase 3 clinical trials.Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017.
P2860
Q34728128-23C72032-ECC2-435C-AE59-67CADB73EC79Q36317577-9B2E44F6-1EEA-4C0C-8B99-D2EE51192291Q36923497-875DEA2D-CDA3-4382-9173-AE523F92A4E0Q37980019-939AC7C2-798F-4FD1-9ACA-B41277F053D2Q38396629-A351CFBC-D722-457D-B4F9-8DFC17D6E1BBQ38420531-BB94A72F-2471-4400-9725-898BBF4B1871Q38498718-E02C647E-C7DA-45F1-B56D-72F11B3D60E1Q41665516-2CDFABE4-E422-4C7F-BF63-16686667D2F3Q44620317-63475D49-FF6D-463E-95F0-03C25798931EQ46637270-0EC09968-5EE3-470B-B54E-3F2ECB60F6E6Q50451370-ED3D4CB0-68CC-433D-B541-6DF835009835Q50620487-83CAC165-CDE9-4E19-98C0-64CE8B428AB0Q51339320-C5273A3B-0B91-42BA-A4AB-FA41FF514174Q55207460-6B205681-9D44-40A9-9F4B-52017A6265A0
P2860
Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Prevalence of cardiovascular d ...... orth Catalonia diabetes study.
@en
Prevalence of cardiovascular d ...... orth Catalonia diabetes study.
@nl
type
label
Prevalence of cardiovascular d ...... orth Catalonia diabetes study.
@en
Prevalence of cardiovascular d ...... orth Catalonia diabetes study.
@nl
prefLabel
Prevalence of cardiovascular d ...... orth Catalonia diabetes study.
@en
Prevalence of cardiovascular d ...... orth Catalonia diabetes study.
@nl
P2093
P2860
P50
P1476
Prevalence of cardiovascular d ...... North Catalonia diabetes study
@en
P2093
Jacint Caula
Jose M Pou
Juan Ybarra
June Hart Romeo
P2860
P304
P356
10.1111/J.1745-7599.2008.00377.X
P577
2009-03-01T00:00:00Z